All filters
Abstracts
The quantification of HBeAg levels differ among the different phases of HBV infection, and can predict therapeutic outcome in the setting of immunosuppression driven HBV reactivation.
L. Piermatteo Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
The effectiveness of the application of serological tests and laboratory indicators as part of RITA for the detection of recent HIV infection
A. Murzakova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates
C. Charpentier Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
TDR surveillance and clinically relevant resistance in Spain: 2019 update
F. García  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of drug resistance mutations to rilpivirine and doravirine among NNRTI-experienced patients in Italy
A. Lai Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HCV resistance associated variants following directly acting agent therapy failure- real life data from Poland
M. Parczewski Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Absence of GS-6207 Phenotypic Resistance in HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, and Isolates With Resistance To Existing Drug Classes
C. Callebaut Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of transmitted resistance mutations to rilpivirine and doravirine in treatment-naive patients in a large clinical and resistance database
F. Lombardi  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Genotyping and treatment issues with unusual 1e and 1g HCV subtypes from African subjects: report of two cases.
C. Caudai Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Susceptibility to bNAbs of transmitted HIV variants among recent infections in France
K. Stefic  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Baseline Hepatitis C Virus NS5A Resistance-Associated Polymorphisms in Patients with and without HIV coinfection in Mexico
B. Lopez Luis Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Substantial clustered transmission of the acute hepatitis C among HIV co-infected men-who-have-sex-with-men (MSM)
D. Van De Vijver Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates
Q. Le Hingrat  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Antiretroviral resistance in patients with multiple treatment failure in a low-middle income setting
J. Castillo-Álvarez  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Late presentation and HIV drug resistance in patients followed in Portugal between 1984-2017
M. Pingarilho Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected in the Republic of Belarus
E. Gasich Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Genetic characteristic of HIV-1 in patients with treatment failure in Kyrgyzstan in 2017-2018.
D. Saleeva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Case of detection of drug resistance mutations hepatitis C virus to the direct-acting antivirals
D. Valutite  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of pretreatment HIV-1 drug resistance among treatment-naïve patients in the Russian Federation, 2014–2018
A. Kirichenko Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
The HBV treatment outcome to cART in HBV/HIV co-Infected patients who failed lamivudine containing regimens
G. Dragovic Lukic Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Hepatotoxicity and the hepatic panel analysis among HIV-positive Ukrainian patients receiving efaverentz and dolutegravir-containing modes
A. Kiurdzhyieva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Feasibility and efficacy assessment of hepatitis B vaccination among adult PLWH and vulnerable population in Vinnytsia region, Ukraine
T. Melnyk Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Natural course of hepatitis C virus infection: which factors affect spontaneous clearance of HCV among the Ukrainian population?
N. Zhandarova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020